{"id":24046,"date":"2026-06-15T10:18:33","date_gmt":"2026-06-15T13:18:33","guid":{"rendered":"https:\/\/jornalpontomais.com\/site\/?p=24046"},"modified":"2026-06-15T10:18:44","modified_gmt":"2026-06-15T13:18:44","slug":"sus-inclui-nova-terapia-para-pacientes-adultos-com-leucemia-mieloide","status":"publish","type":"post","link":"https:\/\/jornalpontomais.com\/site\/2026\/06\/15\/sus-inclui-nova-terapia-para-pacientes-adultos-com-leucemia-mieloide\/","title":{"rendered":"SUS inclui nova terapia para pacientes adultos com leucemia mieloide"},"content":{"rendered":"\n<p>O Minist\u00e9rio da Sa\u00fade passar\u00e1 a inserir, no\u00a0Sistema \u00danico de Sa\u00fade (SUS), o tratamento combinado de venetoclax com azacitidina para pacientes adultos com leucemia mieloide aguda rec\u00e9m-diagnosticada.<img decoding=\"async\" src=\"https:\/\/agenciabrasil.ebc.com.br\/ebc.png?id=1693363&amp;o=node\"><img decoding=\"async\" src=\"https:\/\/agenciabrasil.ebc.com.br\/ebc.gif?id=1693363&amp;o=node\"> A combina\u00e7\u00e3o dos medicamentos \u00e9 indicada a pacientes que, por condi\u00e7\u00f5es cl\u00ednicas, n\u00e3o s\u00e3o eleg\u00edveis ao tratamento padr\u00e3o com quimioterapia intensiva, sendo mais uma alternativa de terapia\u00a0para esse p\u00fablico.<br><br><\/p>\n\n\n\n<p>De acordo com\u00a0<a href=\"https:\/\/www.in.gov.br\/en\/web\/dou\/-\/portaria-sctie\/ms-n-30-de-12-de-junho-de-2026-712054830\" target=\"_blank\" rel=\"noreferrer noopener\">Portaria n\u00ba 30\/2026<\/a>, publicada nesta segunda-feira (15), a nova op\u00e7\u00e3o\u00a0ser\u00e1 disponibilizada na rede p\u00fablica de sa\u00fade em 180 dias, conforme prev\u00ea norma federal que regula a incorpora\u00e7\u00e3o de tecnologias no SUS.<br><br><\/p>\n\n\n\n<p>A medida segue recomenda\u00e7\u00e3o da Comiss\u00e3o Nacional de Incorpora\u00e7\u00e3o de Tecnologias no Sistema \u00danico de Sa\u00fade (Conitec) e est\u00e1 alinhada ao Protocolo Cl\u00ednico do\u00a0<a href=\"https:\/\/www.gov.br\/saude\/pt-br\" target=\"_blank\" rel=\"noreferrer noopener\">Minist\u00e9rio da Sa\u00fade<\/a>.<br><br><\/p>\n\n\n\n<p>O relat\u00f3rio t\u00e9cnico que embasou a decis\u00e3o ficar\u00e1 dispon\u00edvel para consulta p\u00fablica\u00a0<a href=\"https:\/\/www.gov.br\/conitec\/pt-br\" target=\"_blank\" rel=\"noreferrer noopener\">no portal da Conitec<\/a>.\u00a0<br><br><\/p>\n\n\n\n<p><strong>Leucemia<\/strong><\/p>\n\n\n\n<p>Segundo o Minist\u00e9rio da Sa\u00fade,\u00a0a leucemia \u00e9 um tipo de c\u00e2ncer sangu\u00edneo originado na medula \u00f3ssea, tecido respons\u00e1vel por produzir gl\u00f3bulos vermelhos, brancos e plaquetas. Quando h\u00e1 alguma muta\u00e7\u00e3o gen\u00e9tica, esses componentes\u00a0podem se transformar em c\u00e9lulas cancer\u00edgenas.<br><br><\/p>\n\n\n\n<p>Na forma aguda, a doen\u00e7a se torna ainda mais fatal se n\u00e3o tratada de forma precoce. O diagn\u00f3stico nos primeiros est\u00e1gios e o encaminhamento especializado s\u00e3o essenciais para bons resultados do tratamento.\u00a0<br><br><\/p>\n\n\n\n<p>Essa \u00e9 a forma mais comum da leucemia aguda em adultos e atinge, principalmente, pacientes idosos.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>O Minist\u00e9rio da Sa\u00fade passar\u00e1 a inserir, no\u00a0Sistema \u00danico de Sa\u00fade (SUS), o tratamento combinado de venetoclax com azacitidina para pacientes adultos com leucemia mieloide aguda rec\u00e9m-diagnosticada. A combina\u00e7\u00e3o dos medicamentos \u00e9 indicada a pacientes que, por condi\u00e7\u00f5es cl\u00ednicas, n\u00e3o s\u00e3o eleg\u00edveis ao tratamento padr\u00e3o com quimioterapia intensiva, sendo mais uma alternativa de terapia\u00a0para esse [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":24047,"comment_status":"open","ping_status":"open","sticky":true,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[3],"tags":[],"class_list":["post-24046","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-saude"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>SUS inclui nova terapia para pacientes adultos com leucemia mieloide - Jornal Ponto Mais<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/jornalpontomais.com\/site\/2026\/06\/15\/sus-inclui-nova-terapia-para-pacientes-adultos-com-leucemia-mieloide\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SUS inclui nova terapia para pacientes adultos com leucemia mieloide - Jornal Ponto Mais\" \/>\n<meta property=\"og:description\" content=\"O Minist\u00e9rio da Sa\u00fade passar\u00e1 a inserir, no\u00a0Sistema \u00danico de Sa\u00fade (SUS), o tratamento combinado de venetoclax com azacitidina para pacientes adultos com leucemia mieloide aguda rec\u00e9m-diagnosticada. A combina\u00e7\u00e3o dos medicamentos \u00e9 indicada a pacientes que, por condi\u00e7\u00f5es cl\u00ednicas, n\u00e3o s\u00e3o eleg\u00edveis ao tratamento padr\u00e3o com quimioterapia intensiva, sendo mais uma alternativa de terapia\u00a0para esse [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/jornalpontomais.com\/site\/2026\/06\/15\/sus-inclui-nova-terapia-para-pacientes-adultos-com-leucemia-mieloide\/\" \/>\n<meta property=\"og:site_name\" content=\"Jornal Ponto Mais\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-15T13:18:33+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-15T13:18:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/jornalpontomais.com\/site\/wp-content\/uploads\/2026\/06\/int8619.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1170\" \/>\n\t<meta property=\"og:image:height\" content=\"700\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Jornal Ponto Mais\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Jornal Ponto Mais\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/jornalpontomais.com\/site\/2026\/06\/15\/sus-inclui-nova-terapia-para-pacientes-adultos-com-leucemia-mieloide\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/jornalpontomais.com\/site\/2026\/06\/15\/sus-inclui-nova-terapia-para-pacientes-adultos-com-leucemia-mieloide\/\"},\"author\":{\"name\":\"Jornal Ponto Mais\",\"@id\":\"https:\/\/jornalpontomais.com\/site\/#\/schema\/person\/18323f0b0f1355f2490721c48389fe9d\"},\"headline\":\"SUS inclui nova terapia para pacientes adultos com leucemia mieloide\",\"datePublished\":\"2026-06-15T13:18:33+00:00\",\"dateModified\":\"2026-06-15T13:18:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/jornalpontomais.com\/site\/2026\/06\/15\/sus-inclui-nova-terapia-para-pacientes-adultos-com-leucemia-mieloide\/\"},\"wordCount\":271,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/jornalpontomais.com\/site\/#organization\"},\"image\":{\"@id\":\"https:\/\/jornalpontomais.com\/site\/2026\/06\/15\/sus-inclui-nova-terapia-para-pacientes-adultos-com-leucemia-mieloide\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/jornalpontomais.com\/site\/wp-content\/uploads\/2026\/06\/int8619.webp\",\"articleSection\":[\"Sa\u00fade\"],\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/jornalpontomais.com\/site\/2026\/06\/15\/sus-inclui-nova-terapia-para-pacientes-adultos-com-leucemia-mieloide\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/jornalpontomais.com\/site\/2026\/06\/15\/sus-inclui-nova-terapia-para-pacientes-adultos-com-leucemia-mieloide\/\",\"url\":\"https:\/\/jornalpontomais.com\/site\/2026\/06\/15\/sus-inclui-nova-terapia-para-pacientes-adultos-com-leucemia-mieloide\/\",\"name\":\"SUS inclui nova terapia para pacientes adultos com leucemia mieloide - Jornal Ponto Mais\",\"isPartOf\":{\"@id\":\"https:\/\/jornalpontomais.com\/site\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/jornalpontomais.com\/site\/2026\/06\/15\/sus-inclui-nova-terapia-para-pacientes-adultos-com-leucemia-mieloide\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/jornalpontomais.com\/site\/2026\/06\/15\/sus-inclui-nova-terapia-para-pacientes-adultos-com-leucemia-mieloide\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/jornalpontomais.com\/site\/wp-content\/uploads\/2026\/06\/int8619.webp\",\"datePublished\":\"2026-06-15T13:18:33+00:00\",\"dateModified\":\"2026-06-15T13:18:44+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/jornalpontomais.com\/site\/2026\/06\/15\/sus-inclui-nova-terapia-para-pacientes-adultos-com-leucemia-mieloide\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/jornalpontomais.com\/site\/2026\/06\/15\/sus-inclui-nova-terapia-para-pacientes-adultos-com-leucemia-mieloide\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/jornalpontomais.com\/site\/2026\/06\/15\/sus-inclui-nova-terapia-para-pacientes-adultos-com-leucemia-mieloide\/#primaryimage\",\"url\":\"https:\/\/jornalpontomais.com\/site\/wp-content\/uploads\/2026\/06\/int8619.webp\",\"contentUrl\":\"https:\/\/jornalpontomais.com\/site\/wp-content\/uploads\/2026\/06\/int8619.webp\",\"width\":1170,\"height\":700},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/jornalpontomais.com\/site\/2026\/06\/15\/sus-inclui-nova-terapia-para-pacientes-adultos-com-leucemia-mieloide\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\/\/jornalpontomais.com\/site\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SUS inclui nova terapia para pacientes adultos com leucemia mieloide\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/jornalpontomais.com\/site\/#website\",\"url\":\"https:\/\/jornalpontomais.com\/site\/\",\"name\":\"Jornal Ponto Mais\",\"description\":\"As principais not\u00edcias do Brasil e do mundo. Confira!\",\"publisher\":{\"@id\":\"https:\/\/jornalpontomais.com\/site\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/jornalpontomais.com\/site\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/jornalpontomais.com\/site\/#organization\",\"name\":\"Jornal Ponto+\",\"url\":\"https:\/\/jornalpontomais.com\/site\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/jornalpontomais.com\/site\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/jornalpontomais.com\/site\/wp-content\/uploads\/2022\/01\/marca.png\",\"contentUrl\":\"https:\/\/jornalpontomais.com\/site\/wp-content\/uploads\/2022\/01\/marca.png\",\"width\":582,\"height\":148,\"caption\":\"Jornal Ponto+\"},\"image\":{\"@id\":\"https:\/\/jornalpontomais.com\/site\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/jornalpontomais.com\/site\/#\/schema\/person\/18323f0b0f1355f2490721c48389fe9d\",\"name\":\"Jornal Ponto Mais\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/2ee0a9b7fe10fe32bdec8bc086e871e41eb5f4f6ecbcb7b4f2fe0d92d831405f?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/2ee0a9b7fe10fe32bdec8bc086e871e41eb5f4f6ecbcb7b4f2fe0d92d831405f?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/2ee0a9b7fe10fe32bdec8bc086e871e41eb5f4f6ecbcb7b4f2fe0d92d831405f?s=96&d=mm&r=g\",\"caption\":\"Jornal Ponto Mais\"},\"sameAs\":[\"https:\/\/jornalpontomais.com\/site\",\"jornalpontomais\"],\"url\":\"https:\/\/jornalpontomais.com\/site\/author\/jornalpontomais\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SUS inclui nova terapia para pacientes adultos com leucemia mieloide - Jornal Ponto Mais","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/jornalpontomais.com\/site\/2026\/06\/15\/sus-inclui-nova-terapia-para-pacientes-adultos-com-leucemia-mieloide\/","og_locale":"pt_BR","og_type":"article","og_title":"SUS inclui nova terapia para pacientes adultos com leucemia mieloide - Jornal Ponto Mais","og_description":"O Minist\u00e9rio da Sa\u00fade passar\u00e1 a inserir, no\u00a0Sistema \u00danico de Sa\u00fade (SUS), o tratamento combinado de venetoclax com azacitidina para pacientes adultos com leucemia mieloide aguda rec\u00e9m-diagnosticada. A combina\u00e7\u00e3o dos medicamentos \u00e9 indicada a pacientes que, por condi\u00e7\u00f5es cl\u00ednicas, n\u00e3o s\u00e3o eleg\u00edveis ao tratamento padr\u00e3o com quimioterapia intensiva, sendo mais uma alternativa de terapia\u00a0para esse [&hellip;]","og_url":"https:\/\/jornalpontomais.com\/site\/2026\/06\/15\/sus-inclui-nova-terapia-para-pacientes-adultos-com-leucemia-mieloide\/","og_site_name":"Jornal Ponto Mais","article_published_time":"2026-06-15T13:18:33+00:00","article_modified_time":"2026-06-15T13:18:44+00:00","og_image":[{"width":1170,"height":700,"url":"https:\/\/jornalpontomais.com\/site\/wp-content\/uploads\/2026\/06\/int8619.webp","type":"image\/webp"}],"author":"Jornal Ponto Mais","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Jornal Ponto Mais","Est. tempo de leitura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/jornalpontomais.com\/site\/2026\/06\/15\/sus-inclui-nova-terapia-para-pacientes-adultos-com-leucemia-mieloide\/#article","isPartOf":{"@id":"https:\/\/jornalpontomais.com\/site\/2026\/06\/15\/sus-inclui-nova-terapia-para-pacientes-adultos-com-leucemia-mieloide\/"},"author":{"name":"Jornal Ponto Mais","@id":"https:\/\/jornalpontomais.com\/site\/#\/schema\/person\/18323f0b0f1355f2490721c48389fe9d"},"headline":"SUS inclui nova terapia para pacientes adultos com leucemia mieloide","datePublished":"2026-06-15T13:18:33+00:00","dateModified":"2026-06-15T13:18:44+00:00","mainEntityOfPage":{"@id":"https:\/\/jornalpontomais.com\/site\/2026\/06\/15\/sus-inclui-nova-terapia-para-pacientes-adultos-com-leucemia-mieloide\/"},"wordCount":271,"commentCount":0,"publisher":{"@id":"https:\/\/jornalpontomais.com\/site\/#organization"},"image":{"@id":"https:\/\/jornalpontomais.com\/site\/2026\/06\/15\/sus-inclui-nova-terapia-para-pacientes-adultos-com-leucemia-mieloide\/#primaryimage"},"thumbnailUrl":"https:\/\/jornalpontomais.com\/site\/wp-content\/uploads\/2026\/06\/int8619.webp","articleSection":["Sa\u00fade"],"inLanguage":"pt-BR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/jornalpontomais.com\/site\/2026\/06\/15\/sus-inclui-nova-terapia-para-pacientes-adultos-com-leucemia-mieloide\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/jornalpontomais.com\/site\/2026\/06\/15\/sus-inclui-nova-terapia-para-pacientes-adultos-com-leucemia-mieloide\/","url":"https:\/\/jornalpontomais.com\/site\/2026\/06\/15\/sus-inclui-nova-terapia-para-pacientes-adultos-com-leucemia-mieloide\/","name":"SUS inclui nova terapia para pacientes adultos com leucemia mieloide - Jornal Ponto Mais","isPartOf":{"@id":"https:\/\/jornalpontomais.com\/site\/#website"},"primaryImageOfPage":{"@id":"https:\/\/jornalpontomais.com\/site\/2026\/06\/15\/sus-inclui-nova-terapia-para-pacientes-adultos-com-leucemia-mieloide\/#primaryimage"},"image":{"@id":"https:\/\/jornalpontomais.com\/site\/2026\/06\/15\/sus-inclui-nova-terapia-para-pacientes-adultos-com-leucemia-mieloide\/#primaryimage"},"thumbnailUrl":"https:\/\/jornalpontomais.com\/site\/wp-content\/uploads\/2026\/06\/int8619.webp","datePublished":"2026-06-15T13:18:33+00:00","dateModified":"2026-06-15T13:18:44+00:00","breadcrumb":{"@id":"https:\/\/jornalpontomais.com\/site\/2026\/06\/15\/sus-inclui-nova-terapia-para-pacientes-adultos-com-leucemia-mieloide\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/jornalpontomais.com\/site\/2026\/06\/15\/sus-inclui-nova-terapia-para-pacientes-adultos-com-leucemia-mieloide\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/jornalpontomais.com\/site\/2026\/06\/15\/sus-inclui-nova-terapia-para-pacientes-adultos-com-leucemia-mieloide\/#primaryimage","url":"https:\/\/jornalpontomais.com\/site\/wp-content\/uploads\/2026\/06\/int8619.webp","contentUrl":"https:\/\/jornalpontomais.com\/site\/wp-content\/uploads\/2026\/06\/int8619.webp","width":1170,"height":700},{"@type":"BreadcrumbList","@id":"https:\/\/jornalpontomais.com\/site\/2026\/06\/15\/sus-inclui-nova-terapia-para-pacientes-adultos-com-leucemia-mieloide\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/jornalpontomais.com\/site\/"},{"@type":"ListItem","position":2,"name":"SUS inclui nova terapia para pacientes adultos com leucemia mieloide"}]},{"@type":"WebSite","@id":"https:\/\/jornalpontomais.com\/site\/#website","url":"https:\/\/jornalpontomais.com\/site\/","name":"Jornal Ponto Mais","description":"As principais not\u00edcias do Brasil e do mundo. Confira!","publisher":{"@id":"https:\/\/jornalpontomais.com\/site\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/jornalpontomais.com\/site\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/jornalpontomais.com\/site\/#organization","name":"Jornal Ponto+","url":"https:\/\/jornalpontomais.com\/site\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/jornalpontomais.com\/site\/#\/schema\/logo\/image\/","url":"https:\/\/jornalpontomais.com\/site\/wp-content\/uploads\/2022\/01\/marca.png","contentUrl":"https:\/\/jornalpontomais.com\/site\/wp-content\/uploads\/2022\/01\/marca.png","width":582,"height":148,"caption":"Jornal Ponto+"},"image":{"@id":"https:\/\/jornalpontomais.com\/site\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/jornalpontomais.com\/site\/#\/schema\/person\/18323f0b0f1355f2490721c48389fe9d","name":"Jornal Ponto Mais","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/secure.gravatar.com\/avatar\/2ee0a9b7fe10fe32bdec8bc086e871e41eb5f4f6ecbcb7b4f2fe0d92d831405f?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/2ee0a9b7fe10fe32bdec8bc086e871e41eb5f4f6ecbcb7b4f2fe0d92d831405f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/2ee0a9b7fe10fe32bdec8bc086e871e41eb5f4f6ecbcb7b4f2fe0d92d831405f?s=96&d=mm&r=g","caption":"Jornal Ponto Mais"},"sameAs":["https:\/\/jornalpontomais.com\/site","jornalpontomais"],"url":"https:\/\/jornalpontomais.com\/site\/author\/jornalpontomais\/"}]}},"_links":{"self":[{"href":"https:\/\/jornalpontomais.com\/site\/wp-json\/wp\/v2\/posts\/24046","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jornalpontomais.com\/site\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jornalpontomais.com\/site\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jornalpontomais.com\/site\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/jornalpontomais.com\/site\/wp-json\/wp\/v2\/comments?post=24046"}],"version-history":[{"count":1,"href":"https:\/\/jornalpontomais.com\/site\/wp-json\/wp\/v2\/posts\/24046\/revisions"}],"predecessor-version":[{"id":24048,"href":"https:\/\/jornalpontomais.com\/site\/wp-json\/wp\/v2\/posts\/24046\/revisions\/24048"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/jornalpontomais.com\/site\/wp-json\/wp\/v2\/media\/24047"}],"wp:attachment":[{"href":"https:\/\/jornalpontomais.com\/site\/wp-json\/wp\/v2\/media?parent=24046"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jornalpontomais.com\/site\/wp-json\/wp\/v2\/categories?post=24046"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jornalpontomais.com\/site\/wp-json\/wp\/v2\/tags?post=24046"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}